Cargando…

Bioinspired Lipid Nanocarriers for RNA Delivery

[Image: see text] RNA therapy is a disruptive technology comprising a rapidly expanding category of drugs. Further translation of RNA therapies to the clinic will improve the treatment of many diseases and help enable personalized medicine. However, in vivo delivery of RNA remains challenging due to...

Descripción completa

Detalles Bibliográficos
Autores principales: Golubovic, Alex, Tsai, Shannon, Li, Bowen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10125326/
https://www.ncbi.nlm.nih.gov/pubmed/37101812
http://dx.doi.org/10.1021/acsbiomedchemau.2c00073
_version_ 1785030003564478464
author Golubovic, Alex
Tsai, Shannon
Li, Bowen
author_facet Golubovic, Alex
Tsai, Shannon
Li, Bowen
author_sort Golubovic, Alex
collection PubMed
description [Image: see text] RNA therapy is a disruptive technology comprising a rapidly expanding category of drugs. Further translation of RNA therapies to the clinic will improve the treatment of many diseases and help enable personalized medicine. However, in vivo delivery of RNA remains challenging due to the lack of appropriate delivery tools. Current state-of-the-art carriers such as ionizable lipid nanoparticles still face significant challenges, including frequent localization to clearance-associated organs and limited (1–2%) endosomal escape. Thus, delivery vehicles must be improved to further unlock the full potential of RNA therapeutics. An emerging strategy is to modify existing or new lipid nanocarriers by incorporating bioinspired design principles. This method generally aims to improve tissue targeting, cellular uptake, and endosomal escape, addressing some of the critical issues facing the field. In this review, we introduce the different strategies for creating bioinspired lipid-based RNA carriers and discuss the potential implications of each strategy based on reported findings. These strategies include incorporating naturally derived lipids into existing nanocarriers and mimicking bioderived molecules, viruses, and exosomes. We evaluate each strategy based on the critical factors required for delivery vehicles to succeed. Finally, we point to areas of research that should be furthered to enable the more successful rational design of lipid nanocarriers for RNA delivery.
format Online
Article
Text
id pubmed-10125326
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-101253262023-04-25 Bioinspired Lipid Nanocarriers for RNA Delivery Golubovic, Alex Tsai, Shannon Li, Bowen ACS Bio Med Chem Au [Image: see text] RNA therapy is a disruptive technology comprising a rapidly expanding category of drugs. Further translation of RNA therapies to the clinic will improve the treatment of many diseases and help enable personalized medicine. However, in vivo delivery of RNA remains challenging due to the lack of appropriate delivery tools. Current state-of-the-art carriers such as ionizable lipid nanoparticles still face significant challenges, including frequent localization to clearance-associated organs and limited (1–2%) endosomal escape. Thus, delivery vehicles must be improved to further unlock the full potential of RNA therapeutics. An emerging strategy is to modify existing or new lipid nanocarriers by incorporating bioinspired design principles. This method generally aims to improve tissue targeting, cellular uptake, and endosomal escape, addressing some of the critical issues facing the field. In this review, we introduce the different strategies for creating bioinspired lipid-based RNA carriers and discuss the potential implications of each strategy based on reported findings. These strategies include incorporating naturally derived lipids into existing nanocarriers and mimicking bioderived molecules, viruses, and exosomes. We evaluate each strategy based on the critical factors required for delivery vehicles to succeed. Finally, we point to areas of research that should be furthered to enable the more successful rational design of lipid nanocarriers for RNA delivery. American Chemical Society 2023-01-16 /pmc/articles/PMC10125326/ /pubmed/37101812 http://dx.doi.org/10.1021/acsbiomedchemau.2c00073 Text en © 2023 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by-nc-nd/4.0/Permits non-commercial access and re-use, provided that author attribution and integrity are maintained; but does not permit creation of adaptations or other derivative works (https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Golubovic, Alex
Tsai, Shannon
Li, Bowen
Bioinspired Lipid Nanocarriers for RNA Delivery
title Bioinspired Lipid Nanocarriers for RNA Delivery
title_full Bioinspired Lipid Nanocarriers for RNA Delivery
title_fullStr Bioinspired Lipid Nanocarriers for RNA Delivery
title_full_unstemmed Bioinspired Lipid Nanocarriers for RNA Delivery
title_short Bioinspired Lipid Nanocarriers for RNA Delivery
title_sort bioinspired lipid nanocarriers for rna delivery
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10125326/
https://www.ncbi.nlm.nih.gov/pubmed/37101812
http://dx.doi.org/10.1021/acsbiomedchemau.2c00073
work_keys_str_mv AT golubovicalex bioinspiredlipidnanocarriersforrnadelivery
AT tsaishannon bioinspiredlipidnanocarriersforrnadelivery
AT libowen bioinspiredlipidnanocarriersforrnadelivery